Barely Significant
← all excerpts

Intravenous Ferric Carboxymaltose Versus Oral Ferrous Sulfate for Iron Deficiency Anemia: A Retrospective Cohort Study of Iron Store Repletion and Safety.

Cureus · 2026 · PMC13432086 · PMID 42549442

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp<0.001actually significant
Patients receiving IV ferric carboxymaltose achieved a mean post-treatment ferritin of 412.6±95.9 μg/L, compared with 8.7±4.4 μg/L in the oral iron group (Table 4 ), a statistically highly significant difference (p<0.001) representing approximately a 47-fold greater iron store repletion.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.